Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Freemantle

Showing results (261-270 of 300) with videos related to

Pageof 30
Sort By:
Translational Psychiatry|November 7, 2021
Structure and stability of symptoms in first episode psychosis: a longitudinal network approachSiân Lowri Griffiths, Samuel P Leighton, Pavan Kumar Mallikarjun, et al.
BMJ Open|November 30, 2019
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)Joanna Moncrieff, Glyn Lewis, Nick Freemantle, et al.
Trials|June 5, 2019
A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trialLarisa Duffy, Faye Bacon, Caroline S Clarke, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 25, 2014
Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgeryEshan L Senanayake, Neil J Howell, Aaron M Ranasinghe, et al.
Schizophrenia Research|September 11, 2024
Predicting treatment resistance in positive and negative symptom domains from first episode psychosis: Development of a clinical prediction modelRebecca Lee, Sian Lowri Griffiths, Georgios V Gkoutos, et al.
Bjpsych Open|October 25, 2024
Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trialMonica Panca, Robert Howard, Elizabeth Cort, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 4, 2021
Five-year outcome in 18 010 patients from the German Aortic Valve RegistryFriedhelm Beyersdorf, Timm Bauer, Nick Freemantle, et al.
Trials|April 28, 2017
Ketogenic diet in the treatment of epilepsy in children under the age of 2 years: study protocol for a randomised controlled trialSiobhan Titre-Johnson, Natasha Schoeler, Christin Eltze, et al.
BMC Psychiatry|March 16, 2022
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disordersNadia E Crellin, Stefan Priebe, Nicola Morant, et al.
Plos Medicine|October 19, 2022
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19David M Lowe, Li-An K Brown, Kashfia Chowdhury, et al.
Pageof 30

Showing results (261-270 of 300) with videos related to

Sort By:
Pageof 30
Translational Psychiatry|November 7, 2021
Structure and stability of symptoms in first episode psychosis: a longitudinal network approachSiân Lowri Griffiths, Samuel P Leighton, Pavan Kumar Mallikarjun, et al.
BMJ Open|November 30, 2019
Randomised controlled trial of gradual antipsychotic reduction and discontinuation in people with schizophrenia and related disorders: the RADAR trial (Research into Antipsychotic Discontinuation and Reduction)Joanna Moncrieff, Glyn Lewis, Nick Freemantle, et al.
Trials|June 5, 2019
A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trialLarisa Duffy, Faye Bacon, Caroline S Clarke, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 25, 2014
Multicentre double-blind randomized controlled trial of perhexiline as a metabolic modulator to augment myocardial protection in patients with left ventricular hypertrophy undergoing cardiac surgeryEshan L Senanayake, Neil J Howell, Aaron M Ranasinghe, et al.
Schizophrenia Research|September 11, 2024
Predicting treatment resistance in positive and negative symptom domains from first episode psychosis: Development of a clinical prediction modelRebecca Lee, Sian Lowri Griffiths, Georgios V Gkoutos, et al.
Bjpsych Open|October 25, 2024
Cost-utility analysis of adapted problem adaptation therapy for depression in mild-to-moderate dementia caused by Alzheimer's disease: PATHFINDER randomised controlled trialMonica Panca, Robert Howard, Elizabeth Cort, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|May 4, 2021
Five-year outcome in 18 010 patients from the German Aortic Valve RegistryFriedhelm Beyersdorf, Timm Bauer, Nick Freemantle, et al.
Trials|April 28, 2017
Ketogenic diet in the treatment of epilepsy in children under the age of 2 years: study protocol for a randomised controlled trialSiobhan Titre-Johnson, Natasha Schoeler, Christin Eltze, et al.
BMC Psychiatry|March 16, 2022
An analysis of views about supported reduction or discontinuation of antipsychotic treatment among people with schizophrenia and other psychotic disordersNadia E Crellin, Stefan Priebe, Nicola Morant, et al.
Plos Medicine|October 19, 2022
Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19David M Lowe, Li-An K Brown, Kashfia Chowdhury, et al.
Pageof 30